Business Description
Biofarm SA
ISIN : ROBIOFACNOR9
Total Employee Number:
374Compare
Compare
Traded in other countries / regions
BIO.RomaniaH3D.Germany0HTH.UK IPO Date
2008-01-09Description
Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin, and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 204.15 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-EBITDA | 0.01 | |||||
Interest Coverage | 2616.88 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 11.03 | |||||
Beneish M-Score | -2.67 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.1 | |||||
3-Year EBITDA Growth Rate | 11.5 | |||||
3-Year EPS without NRI Growth Rate | 11.1 | |||||
3-Year Book Growth Rate | 12.9 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.93 | |||||
Quick Ratio | 4.26 | |||||
Cash Ratio | 2.46 | |||||
Days Inventory | 440.19 | |||||
Days Sales Outstanding | 160.95 | |||||
Days Payable | 398.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 8.9 | |||||
Shareholder Yield % | 3.07 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 86.32 | |||||
Operating Margin % | 33.05 | |||||
Net Margin % | 31.84 | |||||
EBITDA Margin % | 42.71 | |||||
FCF Margin % | 23.76 | |||||
OCF Margin % | 29.21 | |||||
ROE % | 18.88 | |||||
ROA % | 16.22 | |||||
ROIC % | 24.98 | |||||
3-Year ROIIC % | 35.17 | |||||
ROC (Joel Greenblatt) % | 37.33 | |||||
ROCE % | 21.56 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 13.25 | |||||
PE Ratio without NRI | 13.38 | |||||
Shiller PE Ratio | 18.78 | |||||
Price-to-Owner-Earnings | 15 | |||||
PEG Ratio | 1.39 | |||||
PS Ratio | 4.24 | |||||
PB Ratio | 2.31 | |||||
Price-to-Tangible-Book | 2.37 | |||||
Price-to-Free-Cash-Flow | 17.73 | |||||
Price-to-Operating-Cash-Flow | 14.52 | |||||
EV-to-EBIT | 9.65 | |||||
EV-to-EBITDA | 8.24 | |||||
EV-to-Revenue | 3.52 | |||||
EV-to-FCF | 14.81 | |||||
Price-to-GF-Value | 1.58 | |||||
Price-to-Projected-FCF | 1.48 | |||||
Price-to-DCF (Earnings Based) | 0.12 | |||||
Price-to-DCF (FCF Based) | 0.27 | |||||
Price-to-Median-PS-Value | 1.98 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.58 | |||||
Price-to-Graham-Number | 1.19 | |||||
| Price-to-Net-Current-Asset-Value | 3.95 | |||||
| Price-to-Net-Cash | 11.85 | |||||
Earnings Yield (Greenblatt) % | 10.36 | |||||
FCF Yield % | 5.6 | |||||
Forward Rate of Return (Yacktman) % | 11.91 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biofarm SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil lei) | 316.746 | ||
| EPS (TTM) (lei) | 0.103 | ||
| Beta | -0.3059 | ||
| 3-Year Sharpe Ratio | -54.52 | ||
| 3-Year Sortino Ratio | -3.46 | ||
| Volatility % | 60.12 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (lei) | - | ||
| 20-Day SMA (lei) | 0.237 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (lei) | 0.237 - 0.237 | ||
| Shares Outstanding (Mil) | 985.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biofarm SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biofarm SA Stock Events
| Event | Date | Price (lei) | ||
|---|---|---|---|---|
| RON 0.140263 Cash Dividend | 2026-06-29 | 0.24 (+0.00%) | ||
| RON 0.042000 Cash Dividend | 2026-05-13 | 0.24 (+0.00%) | ||
| RON 0.031000 Cash Dividend | 2025-08-18 | 0.24 (+0.00%) | ||
| RON 0.031000 Cash Dividend | 2024-08-20 | 0.24 (+0.00%) |
Show
Entries
Biofarm SA Frequently Asked Questions
What is Biofarm SA(LTS:0HTH)'s stock price today?
The current price of LTS:0HTH is lei0.24. The 52 week high of LTS:0HTH is lei0.24 and 52 week low is lei0.24.
When is next earnings date of Biofarm SA(LTS:0HTH)?
The next earnings date of Biofarm SA(LTS:0HTH) is .
Does Biofarm SA(LTS:0HTH) pay dividends? If so, how much?
Biofarm SA(LTS:0HTH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Biofarm SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers